Description

7-tert-Butyl 2-Ethyl 3-Bromo-5,6-Dihydroimidazo[1,2-A]Pyrazine-2,7(8H)-Dicarboxylate is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is of significant value for medicinal chemistry research and development, serving as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers focused on developing new therapeutic agents, particularly in areas requiring sophisticated molecular scaffolds.

Application

• Pharmaceutical Intermediate: A key precursor in the multi-step synthesis of novel drug candidates targeting various disease pathways.
• Medicinal Chemistry Research: Used as a versatile scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• API Synthesis: Employed in the construction of complex heterocyclic cores present in potential therapeutics for central nervous system (CNS) disorders, oncology, or infectious diseases.
• Chemical Biology Probe Development: Serves as a starting material for creating tool compounds to study biological targets and mechanisms.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.
• Academic Research: Used in university and institutional labs for methodological development in organic synthesis and heterocyclic chemistry.

Basic Information

Product Name	7-tert-Butyl 2-Ethyl 3-Bromo-5,6-Dihydroimidazo[1,2-A]Pyrazine-2,7(8H)-Dicarboxylate
CAS No.	1000576-75-9
Molecular Formula	C16H22BrN3O4
Molecular Weight	400.27 g/mol
Synonyms	tert-Butyl 2-ethyl 3-bromo-5,6-dihydroimidazo[1,2-a]pyrazine-2,7(8H)-dicarboxylate; 3-Bromo-5,6-dihydroimidazo[1,2-a]pyrazine-2,7(8H)-dicarboxylic acid 7-(1,1-dimethylethyl) 2-ethyl ester; 2-Ethyl 7-tert-butyl 3-bromo-5,8-dihydroimidazo[1,2-a]pyrazine-2,7-dicarboxylate; 7-(tert-Butoxycarbonyl)-2-(ethoxycarbonyl)-3-bromo-5,6-dihydroimidazo[1,2-a]pyrazine; BOC-Protected 3-Bromoimidazopyrazine Ester; CAS 1000576-75-9
EINECS	Contact for details

Quality Control

Our production of 7-tert-Butyl 2-Ethyl 3-Bromo-5,6-Dihydroimidazo[1,2-A]Pyrazine-2,7(8H)-Dicarboxylate adheres to stringent quality management protocols. Each batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and MS for structural confirmation, and residual solvent analysis. Certificates of Analysis (COA) detailing all specifications are provided to ensure traceability and compliance with your research or cGMP guidelines for intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep the container tightly sealed under an inert atmosphere if prolonged storage is anticipated to maintain optimal stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (HPLC)	Conforms to reference standard
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residual Solvents (GC)	Meets ICH Q3C guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.